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The development of sustainable processes for the valorization
of byproducts and other waste streams remains an ongoing
challenge in the field of catalysis. Racemic borneol, isoborneol
and camphor are currently produced from α-pinene, a side
product from the production of cellulose. The pure enantiomers
of these monoterpenoids have numerous applications in
cosmetics and act as reagents for asymmetric synthesis, making
an enzymatic route for their separation into optically pure
enantiomers a desirable goal. Known short-chain borneol-type
dehydrogenases (BDHs) from plants and bacteria lack the
required specificity, stability or activity for industrial utilization.
Prompted by reports on the presence of pure (  )-borneol and
(  )-camphor in essential oils from rosemary, we set out to
investigate dehydrogenases from the genus Salvia and discov-
ered a dehydrogenase with high specificity (E>120) and high
specific activity (>0.02 Umg  1) for borneol and isoborneol.
Compared to other specific dehydrogenases, the one reported
here shows remarkably higher stability, which was exploited to
obtain the first three-dimensional structure of an enantiospe-
cific borneol-type short-chain dehydrogenase. This, together
with docking studies, led to the identification of a hydrophobic
pocket in the enzyme that plays a crucial role in the stereo
discrimination of bornane-type monoterpenoids. The kinetic
resolution of borneol and isoborneol can be easily integrated
into the existing synthetic route from α-pinene to camphor
thereby allowing the facile synthesis of optically pure mono-
terpenols from an abundant renewable source.
Introduction
The enantiospecificity of many enzymes is a key feature that is
currently exploited for numerous biotechnological processes.
Often, increase or inversion of the specificity by enzyme
engineering is necessary, for which an understanding of the
molecular mechanisms of enantiospecificity becomes crucial.
Several short-chain dehydrogenases-reductases (SDR) exert an
intriguing two-fold stereospecificity in the conversion of chiral
monoterpenoids and could potentially be exploited for the
synthesis of pure ingredients from essential oils.[1] These
enzymes catalyze the kinetic resolution of racemic alcohols and
are also capable of forming a stereocenter by the asymmetric
reduction of an enantiotopic or diastereotopic keto-group.
Terpenes are a structurally and functionally diverse group of
molecules. Their diversity is generated by the outstanding
selectivity of the biosynthetic enzymes that participate in both
the formation of the hydrocarbon skeleton and its oxyfunction-
alization and further decoration.[2,3] Among the vast diversity of
bioactive terpenoids are the bornane-type bicyclic monoterpe-
noids borneol (endo-1 a) and isoborneol (exo-1 a) and their
corresponding ketone, camphor (1 b) (Scheme 1). They are
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found in essential oil extracts from different plants. Their pure
isomers, and synthetic mixtures thereof, are widely used in
Chinese medicine.[4] Different studies have suggested their
activity as anti-inflammatory, neuroprotective and vasorelaxant
agents, making them valuable ingredients for health-related
formulations.[5] Derivatives of optically pure isoborneol such as
(2S)-(  )-3-exo-(morpholino)isoborneol and (2S)-(  )-3-exo-
(dimethylamino)isoborneol also find application as chiral
ligands in asymmetric synthesis.[6,7]
The biosynthesis of 1 b proceeds from the cyclization and
subsequent hydrolysis of geranyl diphosphate by borneol
diphosphate synthase and borneol synthase.[8] Enzymatic
oxidation of 1 a by an alcohol dehydrogenase then gives rise to
1 b. This biosynthetic pathway does not necessarily require an
enantiospecific borneol dehydrogenase as (+)-endo-1 a is
produced from geranyl pyrophosphate already in optically pure
form. In fact, the first recombinantly produced borneol dehy-
drogenases from the plants Artemisia annua[9,10] and Lavandula
intermedia,[11] and the bacterium Pseudomonas sp. TCU-HL1[12]
did not show any significant enantiospecificity, which seemed
to confirm this notion.
Racemic 1 b can easily be obtained by chemical synthesis
from α- and β-pinene with racemic 1 a as intermediate.[13] As α-
and β-pinene are side-streams in the processing of pine trees,
intermediates of this route represent inexpensive starting
material for the production of optically pure isomers of bornane
type monoterpenoids.[13] This can be achieved by the kinetic
resolution of rac-1 b using a dehydrogenase that is enantiospe-
cific towards 1 b and diastereoselective for the formation of
(+)-endo-1 a. Using iterative saturation mutagenesis, we re-
cently created the first described variant of a bacterial short-
chain dehydrogenase capable of doing this.[14] Alternatively, the
oxidative kinetic resolution of rac-exo-1 a as intermediate of the
existing chemical route is shorter and would provide a clean
alternative to the isolation process from plants.[15]
In the 1980’s, Croteau and coworkers reported the presence
of (+)-specific borneol dehydrogenase activity in sage leaf
homogenate (Salvia officinalis L.).[16] Additionally, the essential
oil from the related Salvia rosmarinus is reported to contain a
high relative content of (  )-endo-1 a and (  )-1 b.[17] Based on
the hypothesis that the synthesis of optically pure 1 a and 1 b
isomers in Salvia species would require highly enantiospecific
enzymes, we previously identified two dehydrogenases from S.
officinalis L. that catalyze the specific oxidation of (+)-endo-1 a
with outstanding enantiospecificity (E>200).[1] The enantiopre-
ference of these enzymes was at first sight unexpected, as the
enzymes preferentially produced (+)-1 b from racemic endo-1 a,
but (  )-1 b from racemic exo-1 a.[1] Unfortunately, the low
activity and stability of both enzymes represented an obstacle
for synthetic application and structure elucidation. In order to
find an enzyme with higher stability and to understand whether
enantiospecificity is a frequent feature or an exception in this
group of dehydrogenases, we continued studying other
enzymes from the Salvia genus, specifically, S. rosmarinus and S.
officinalis. We also investigated the capability of these plant
dehydrogenases to perform the reverse reaction. Herein, we
report the specificity, substrate scope and activity of a set of
plant borneol-type dehydrogenases, with special emphasis on
the highly stable and active borneol dehydrogenase SrBDH1
from S. rosmarinus. We also determined the structure of SrBDH1
in complex with NAD+ at 2.8 Å resolution. This represents the
first structure of a selective borneol-type SDR; from which a
deeper insight into the molecular basis of the enantiospecificity
of the enzyme was obtained.
Results and discussion
Sequence analysis
Two putative members of the SDR class from the genome S.
rosmarinus and one from S. officinalis L.[18] were identified using
the BLASTP server. The percentage of identity with the
unselective AaADH2 (Artemisia annua)[10] ranged between 43%
and 53%, making them likely candidates for borneol-converting
dehydrogenases. For S. officinalis L., the two first hits had
already been shown to convert (+)-endo-1 a in an enantiospe-
cific fashion (SoBDH1 and SoBDH2).[1] The three putative
dehydrogenases have the typical TGxxx[AG]xG cofactor binding
motif and the YxxxK active site motif that is characteristic to the
classic SDR family (Figure S1).[19] According to the classification
suggested by Kallberg et al. (2010)[20] all of the alcohol
dehydrogenases investigated in this paper (except the bacterial
borneol dehydrogenase from Pseudomonas sp. TCU-HL1
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(PsBDH)) belong to the SDR110 C subgroup of the SDR super-
family (hereafter, borneol-type dehydrogenases). Other mem-
bers are the sex determination protein tasselseed-2 from Zea
mays (ZmSDP) and secoisolariciresinol dehydrogenase from
Podophyllum peltatum (PeSDH), which show a wide diversity in
terms of function and substrate acceptance within the sub-
group (Figure 1). Other subgroups displayed in the phyloge-
netic tree are tropinone reductase-like SDRs (SDR65 C), menthol
dehydrogenase-like SDRs (SDR114 C) and carbonyl reductases
(SDR21 C).
Recombinant production and substrate scope
The recombinant production in E. coli and subsequent
purification of the three enzymes yielded ~50 mg L  1 for
SrBDH1, and values in the same range for SrBDH2 and SoBDH3
(Figure S2). Size exclusion chromatography classifies the en-
zymes as tetramers (Figure S3). SrBDH1 had a specific activity of
0.030 U mg  1 towards rac-endo-1 a, the highest value among
borneol-type dehydrogenases from plants. pH stability analysis
showed over 50% retention of activity for pH values between 5
and 10.5 after 30 min of incubation at the selected pH
(Figure 2A). After 24 h of incubation, the activity showed little
variation for pH between 5.5 and 10.5 (Figure 2B). This relatively
Figure 1. Phylogram showing evolutionary relationships of different short-chain dehydrogenases. The tree was constructed using Maximum Likelihood
method with Mega X software. The three borneol-type dehydrogenases characterized in this paper are highlighted in blue. Specificity for endo-1 a and exo-1 a
is indicated in circles, with high specificity in blue (E>100) and low specificity in orange. Enzymes described to convert 1 a with no indicated specificity are
shown with grey circles and enzymes not described to convert it are shown with white. The bootstrap values are shown next to each branch. For the
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high stability at a broad pH range is particularly interesting for
reduction reactions, which are favored at an acidic pH. It is also
observed from Figure 2 that after 24 h of incubation at neutral
pH values, the enzyme still retained 50% of its initial activity.
This is a very promising starting point for further optimization
by protein and reaction engineering. The higher stability of
SrBDH1 in comparison to previously investigated enzymes from
S. officinalis L., also allowed us to successfully elucidate its
crystal structure.
Determination of the specific activities of the BDHs in the
oxidation of a set of primary and secondary alcohols showed
that the enzymes do not exclusively oxidize bicyclic mono-
terpenols; they also accept monocyclic and linear substrates
(Figure 3, Table 1). The dehydrogenases clearly favor secondary
alcohols over primary alcohols. All enzymes had the highest
specific activity either for endo-1 a (SrBDH1 and PsBDH),
(  )-carveol (4 a) (SrBDH2, SoBDH3 and AaADH2) or 3-methyl
cyclohexanol (7 a) (SoBDH2).
Interestingly, we noted that none of the enzymes oxidized
menthol (9 a), despite its structural similarity to 4 a. In fact,
menthol dehydrogenases appear as a separated clade in the
phylogram (Figure 1, MMR and MNR). A BLASTP search using
menthol and neomenthol dehydrogenases from Mentha x
piperita as queries suggests that this subfamily of SDRs is also
present in S. officinalis and S. rosmarinus (best hits with 67%
identity for MNR and 68% identity for MMR), leading us to think
that Salvia plants have independent biocatalysts for the syn-
thesis of menthone-like compounds and camphor-like com-
Figure 2. Rates for conversion of (+)-endo-1 a for SrBDH1 after incubation at different pH values. The enzyme was incubated at room temperature for 30 min
(A) and 24 h (B) at the indicated pH and then the initial rate of oxidation of (+)-endo-1 a was determined at pH 9 by following NADH formation at 340 nm.
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pounds. We also noted differences in the specific activities
obtained for the unnatural substrate cyclohexanol (5 a) and the
isomers 2-methylcyclohexanol (6 a), 3-methylcyclohexanol (7 a)
and 4-methylcyclohexanol (8 a). For SrBDH1, SrBDH2 and
SoBDH2 we observed a higher specific activity for 6 a in
comparison to 5 a. This situation is similar to what we observed
with endo-1 a vs endo-2 a, where the presence of methyl groups
seems to improve the fit in the active site, making the reaction
faster. Conversely, the unselective enzymes AaADH2 and PsBDH
have a higher specific activity for the alcohol without the
methyl group, 5 a. The specific activities observed for SrBDH1
with endo-1 a and exo-1 a are the best among the selective
enzymes studied and fall within the same range of the
unselective borneol dehydrogenase from A. annua AaADH2,
making SrBDH1 interesting for biocatalytic applications. Cofac-
tor usage was also studied spectrophotometrically. Results
showed that AaADH2 was the only enzyme also capable of
using NADP+, albeit less efficiently than NAD+. The other tested
enzymes did not show measurable activity for NADP+ (Fig-
ure S4).
Enantiospecificity and selectivity towards bicyclic alcohols
and ketones
To obtain a more systematic overview on the enantiospecificity
of the dehydrogenases, we investigated the kinetic resolution
of the three bornane type monoterpenols endo-1 a, exo-1 a and
fenchol (endo-3 a) and the structurally related exo-norborneol
(exo-2 a) (Table 2, Scheme 2). SoBDH1 and SrBDH1 showed
outstanding enantiospecificity (E>200) towards both endo-1 a
and exo-1 a, while SoBDH2 and SrBDH2 showed specificity for
endo-1 a, but not for exo-1 a. The differences in the specificity of
this set of enzymes towards exo-1 a and the smaller exo-2 a
were striking. In particular, SoBDH1 and SrBDH1 were hardly
specific towards exo-2 a, in contrast with exo-1 a, which might
be an indication that a precise fit of the substrate is important
for the specificity of both enzymes. It should be noted,
however, that the activity of SrBDH1 towards exo-2 a is
substantially lower than towards exo-1 a, making comparisons
of the specificity difficult. SrBDH1 shows a similar drop in
activity and specificity in the conversion of the structural isomer
endo-3 a (Table 2, Scheme 2). The differences in activity and
selectivity of SrBDH1 towards these substrates indicates that
the position of the methyl substituents is crucial for the
substrate recognition of this enzyme. Therefore, the high
specificity of SrBDH1 and SoBDH1 towards both endo-1 a and
exo-1 a is somehow counterintuitive and led us to think that
these two enzymes share key active pocket configurations that
other BDHs lack. None of the plant dehydrogenases have any
noteworthy specificity in the resolution of endo-3 a. While the
investigated enzymes share the enantiopreference for the same
isomer of endo-1 a, exo-1 a and exo-2 a, we noted that the
preference for the (+) and (  ) isomers of endo-3 a differed.
PsBDH displays a different behavior in comparison to plant
BDHs, as the bacterial enzyme showed very low specificity
towards endo-1 a, exo-1 a and exo-2 a, but it is the most specific
of the studied enzymes for the oxidation of endo-3 a, with
>99% ees and E=27. SoBDH3 was not active towards endo-1 a
and exo-2 a and showed little conversion for exo-1 a, leading us
to assume that this enzyme has a natural substrate with
significant structural differences from endo-1 a, which is re-
flected in the divergent sequence compared to other BDHs
from plants (Figure 1).
Based on reports describing a short-chain dehydrogenase
from the tropinone reductase subfamily capable of catalyzing
Table 1. Specific activities measured for different borneol-type dehydrogenases.
Specific activity [mU/mg] [a]
Substrate SrBDH1[b] SrBDH2[b] SoBDH3[b] AaADH2[b] SoBDH2[b] PsBDH[b]
exo-1 a 24 5.1 0.3 53 13 115
endo-1a 30 10.0 n.c.[c] 22 18 122
exo-2 a 4.8 1.5 n.c. 29 n.c. 69
(+)-endo-2 a 3.9 5.9 n.c. 23 n.d. 28
endo-3a 4.6 1.0 n.c. 14 7.1 30
4 a 2.9 16 0.46 88 12 5.0
5 a 3.3 n.c. n.c. 29 6.7 28
6 a 10 2.5 n.c. 17 18 23
7 a 4.4 n.c. 0.23 21 39 18
8 a 8.3 n.c. 0.21 15 3.8 11
9 a n.c. n.c. n.c. n.c. n.c. n.c.
10 a n.c. n.c. n.c. 5.9 n.c. n.c.
11 a n.c. n.c. n.c. n.c. n.c. n.c.
12 a 13 4.4 n.c. 8.7 2.3 43
13 a 9.8 2.0 n.c. 63 6.3 6.2
14 a n.c. n.c. n.c. 10.0 n.c. n.c.
15 a n.c. n.c. n.c. n.c. 3.4 n.c.
16 a n.c. n.c. n.c. 4.8 4.7 n.c.
17 a 3.3 n.c. 0.2 n.c. 6.5 3.2
[a] The highest activity for each enzyme is highlighted in bold letters. For the experimental error from technical triplicates, please refer to Table S1, [b]
AaADH2: alcohol dehydrogenase from A. annua[10]; SoBDH2: borneol dehydrogenase from S. officinalis L.[1]; SrBDH1/2: borneol- like dehydrogenases from S.
rosmarinus; SoBDH3: borneol-like dehydrogenase from S. officinalis L.; PsBDH: borneol dehydrogenase from Pseudomonas sp. TCU-HL1.[12], [c] n.c.=no
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the stereoselective reduction of pure 1 b isomers,[21] and an
engineered Pseudomonas dehydrogenase with high enantiospe-
cificity towards (+)-1 b,[14] we decided to investigate if borneol-
type dehydrogenases were also capable of catalyzing the
reduction. The reduction reaction is favored at acidic pH values,
however, we used pH 5.5 as the stability of SrBDH1 was notably
Table 2. Kinetic resolution of racemic secondary alcohols of the bornane and norbornane types catalyzed by alcohol dehydrogenases at a substrate
concentration of 1 mM.
AaADH2[a] SoBDH1 [a] SoBDH2[a] SoBDH3[b] SrBDH1[b] SrBDH2[b] PsBDH [a]
exo-1 a Time (h) 0.5 24 4 48 2 48 0.5
Specificity (+) (+) (+) (+) (+) (+) (+)
%eep
[c] 4% 99% 13% >99% >99% 31% 4%
%ees
[c] 99% 30% 99% 5% 52% 32% 27%
%c 96% 28% 88% 5% 34% 51% 87%
E[f] n.d. >200 4.6 n.d. >200 3 1.3
endo-1 a Time (h) 0.5 24 4 n.c.[d] 2 48 0.5
Specificity (+) (+) (+) n.c. (+) (+) (+)
%eep
[c] 46% >99% >99% n.c. >99% >99% 17%
%ees
[c] 83% 18% 49% n.c. 77% 23% 50%
%c 64% 22% 33% n.c. 44% 19% 75%
E[f] 6.6 >200 >200 n.d. [e] >200 >200 2.1
exo-2 a Time (h) 0.25 48 48 n.c. 48 48 0.25
Specificity (  ) (  ) (  ) n.c. (  ) (  ) (  )
%eep
[c] 65% 10% 80% n.c. 75% 49% 9%
%ees
[c] 53% 3% 15% n.c. 10% 1% 2%
%c 45% 22% 16% n.c. 12% 2% 18%
E[f] 7.9 1.2 10.3 n.d. 7.7 n.d 1.2
endo-3 a Time (h) 0.25 n.c. 48 48 48 48 48
Specificity (+) n.c. (  ) n.d. (+) (  ) (+)
%eep
[c,g] - n.c. - - - - -
%ees
[c] 13% n.c. 84% <1% 26% 6% >99%
%c 67% n.c. 58% 22% 45% 10% 59%
E[f] 1.3 n.d. 10 1 2.5 3.7 27
[a] Data from literature for endo-1 a and exo-1 a.[1]; AaADH2: alcohol dehydrogenase from A. annua.[10]; SoBDH1/2: borneol-type dehydrogenases from S.
officinalis L.[1]; PsBDH: borneol dehydrogenase from Pseudomonas sp. TCU-HL1,[12] [b] SoBDH3: borneol- type dehydrogenases from S. officinalis; SrBDH1/2:
borneol- type dehydrogenases from S. rosmarinus, [c] %ees: Enantiomeric excess of substrates. %eep: Enantiomeric excess of the products. All enantiomeric
excess were determined by chiral gas chromatography. [d] n.c.: no conversion, [e] n.d.: not determined, [f] Calculated according to Straathop and Jogejan
(1997).[53] [g] %eep not calculated as we did not obtain baseline separation for the fenchone enantiomers in GC analysis.
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reduced at lower pH values (Figure 2). In fact, all of the enzymes
showed some degree of precipitation at pH 5.0. Among
borneol-type dehydrogenases, AaADH2 and SrBDH1 were the
only ones that catalyzed the reduction of 1 b (Table 3). SrBDH1
exclusively produced (+)-endo-1 a from pure (+)-1 b and
(+)-exo-1 a from pure (  )-1 b (dep>99% for both) (Table S2). As
the enzyme converts both enantiomers of 1 b, reduction of rac-
1 b produces a mixture of (+)-endo-1 a and (+)-exo-1 a in the
ratio 91 :9. AaADH2 showed lower diastereoselectivity and
produced (+)-endo-1 a with 89% dep and (+)-exo-1 b with 94%
dep, respectively (Scheme 3, Figure S5). Intriguingly, all of the
enzymes, except SrBDH1, showed a higher conversion for 2 b in
comparison to 1 b, while for the oxidations, we obtained better
conversion for endo-1 a and exo-1 a compared to exo-2 a. Also
from the DR in the reductions, we observe endo predominance
in all cases, leading us to think that endo-2 a would be better
oxidized than exo-2 a for the studied enzymes. In the case of
3 b, the only enzyme catalyzing the reduction was AaADH2. This
last result also contrasts with the capacity of catalyzing the
oxidation of endo-3 a observed in all the studied enzymes, and
Table 3. Reduction of racemic bicyclic ketones catalyzed by alcohol dehydrogenases at a substrate concentration of 5 mM.
AaADH2[a] SoBDH1[a] SoBDH2[a] SoBDH3[a] SrBDH1[a] SrBDH2[a] PsBDH[a]
rac-1 b Time (h) 48 n.c.[e] n.c. n.c. 48 n.c. 48
Specificity (+) n.c. n.c. n.c. (+) n.c. (+)
%c 51% n.c. n.c. n.c. 31% n.c. 22%
%ees
[b] 10% n.c. n.c. n.c. 36% n.c. 11%
%eep
[b] 10% n.c. n.c. n.c. 80% n.c. 37%
E [c] 1.3 n.c. n.c. n.c. 12.4 n.c. 2.4
DR[d] 44 :3 : 51 :2 n.c. n.c. n.c. 91:0 : 9:0 n.c. 65 :24 :5 : 5
rac-2 b Time (h) 4 48 48 n.c. 48 48 48
Specificity (+) (  ) (  ) n.c. (  ) (  ) (  )
%c 94% 2% 7% n.c. 30% 2% 88%
%ees
[b] 60% <1% 69% n.c. 33% 1% 38%
%eep
[b] 4% 19% 85% n.c. 76% 51% 5%
E [c] 1.6 n.d.[f] 5.8 n.c. 10 n.d. 1.4
DR[d] 13 :41 :7 : 39 36 :41 :18 :4 10 :85:0 : 6 n.c. 6 : 87:0 : 6 14 :68 :7 : 10 22 :37 :16 :26
rac-3 b Time (h) 48 n.c. n.c. n.c. n.c. n.c. n.c.
Specificity (+) n.c. n.c. n.c. n.c. n.c. n.c.
%c 49% n.c. n.c. n.c. n.c. n.c. n.c.
%ees
[b] 9% n.c. n.c. n.c. n.c. n.c. n.c.
%eep
[b] 9% n.c. n.c. n.c. n.c. n.c. n.c.
E [c] 1.3 n.c. n.c. n.c. n.c. n.c. n.c.
DR[d] 40 :54 :5:0 n.c. n.c. n.c. n.c. n.c. n.c.
[a] AaADH2: ADH from A. annua.[10]; SoBDH2: borneol dehydrogenase from S. officinalis L.[1]; SrBDH1/2: borneol- like dehydrogenases from S. rosmarinus;
SoBDH3: borneol-like dehydrogenase from S. officinalis L. PsBDH: borneol dehydrogenase from Pseudomonas sp. TCU-HL1.[12] [b] %ees: percentage
enantiomeric excess of substrates. %eep: percentage enantiomeric excess of the products. All enantiomeric excess were determined by chiral gas
chromatography. The enantiomeric excess of the product was calculated based on the sums of the products resulting from (+)-1 b and (  )-1 b, (+)-2 b and
(  )-2 b or (+)-3 b and (  )-3 b, respectively. For instance, the eep for the conversion of 1 is defined as eep= (([(+)-exo-1 a]+ [(  )-endo-1 a])-([(  )-exo-1 a]+
[(+)-endo-1 a]))/(([(+)-exo-1 a]+ [(  )-endo-1 a])+ ([(  )-exo-1 a]+ [(+)-endo-1 a])), [c] calculated according to Straathop and Jogejan (1997),[53] [d] DR:
diastereomer ratio: (+)-endo-a : (  )-endo-a : (+)-exo-a : (  )-exo-a. [e] n.c.: no conversion. [f] n.d. : not determined;
Scheme 3. Reduction of racemic and pure enantiomers of 1 b by SrBDH1 at pH 5.5 with phosphite dehydrogenase as cofactor-regeneration system. Reaction
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could be indicating, for instance, an inhibiting effect caused by
exo-3 a, which we did not analyze for oxidation reactions.
Kinetic parameters of SrBDH1
The high activity of SrBDH1 stood out amongst this family of
enzymes. While the poor solubility of (+)-endo-1 a limited the
determination of initial rates to concentrations up to 6 mM
(three-fold of the KM-value), the apparent kobs obtained corre-
sponds to 0.20 s  1 (Figure S6). This value is higher by at least
two orders of magnitude compared with those of related
dehydrogenases from S. officinalis L. (0.005 s  1),[1] A. annua
(0.006 s  1),[9] L. intermedia (0.0004 s  1)[11] and one order of
magnitude compared with tropinone reductase from Cochlearia
officinalis CoTR (0.09 s  1 towards (  )-endo-1a).[21] The value is
comparable to the non-specific bacterial PsBDH from Pseudo-
monas sp. TCU-HL1 (0.75 s  1).[12] The KM-value of 2.02�0.18 mM
is surprisingly high compared to those of the other plant
dehydrogenases (typically 50 μM[1]). At a non-saturating concen-
tration of (+)-endo-1 a, the KM-value estimated for NAD
+ was
100�26 μM, which is comparable to the KM for NAD
+
determined for SoBDH2.[1]
Structure elucidation and comparison with PsBDH of
Pseudomonas sp. TCU-HL1
SrBDH1 crystals were obtained under two different crystalliza-
tion conditions. The first one with high concentrations of NaCl
and the second one using the polymer pentaerythritol propox-
ylate (PO/OH). The obtained crystals belong to two different
space groups (Table S3) with different crystal packing. The
overall architecture of SrBDH1 in crystallo is tetrameric (Fig-
ure S7), in agreement with SEC/MALS measurements confirming
a tetrameric state in solution (Figure S8). The tetramers as
obtained from both crystallization conditions are practically
undistinguishable with a root mean square deviation (RMSD) of
0.435 Å for 258 pairs of Cα atoms. As a member of the
superfamily of short-chain dehydrogenases/reductases (SDR),[22]
SrBDH1 folds into the characteristic Rossmann-like fold,[23] that
harbors the cofactor NAD+, and has an additional short α-helix
at the C-terminus (Figure 4, Figure S7). A closer inspection of
both structures revealed remarkable differences in the cofactor
binding sites. In the structure obtained from crystals under the
high salt condition, we saw a defined electron density for the
NAD+ cofactor in only one monomer (Figure S7). Notably, no
NAD+ was added during protein purification or crystallization,
therefore NAD+ was co-purified with SrBDH1. Hence, the
structure represents the binary complex (SrBDH1 ·NAD+ /high
salt). Binding of NAD+ leads to a defined folded loop region
from residue V197 to S203. The well-defined loop conformation
might be a consequence of crystal packing, which hampers
dissociation of the cofactor. The apo structure of SrBDH1
(Table S3) lacks electron density for NAD+, and the latter loop
region is not defined. The remaining apo structure is practically
indistinguishable from the structure of the binary complex.
In contrast, we do observe electron density for all four
cofactor binding sites in the structure obtained under the PO/
OH crystallization condition (SrBDH·NAD+/PO/OH) (Figure S7).
The electron density clearly shows different sigma levels at the
supposed binding groove for NAD+, indicating different
occupancies of the NAD+ across the four monomers.
The active site is mainly lined by hydrophobic residues (V97,
G99, I154, A155, F190, G191, I196, V197, and M211) and is
composed of F260 from a symmetry-related molecule (Fig-
ure 4C and D and Figure S7A). The NAD+, as well as the strictly
conserved catalytic residues S146, Y159, and K163, complete
the active site. For other studied SDRs, during oxidation, the
hydroxyl group of the tyrosine abstracts a proton from the
substrate. The adjacent lysine enhances the acid/base proper-
ties of the tyrosine, and the serine stabilizes and polarizes the
carbonyl group of the substrate.[24] Activity loss of the enzyme
after substitution of S146 and Y159 to alanine confirmed their
catalytic role.
Recently, the crystal structure of the unspecific PsBDH of
Pseudomonas sp. TCU-HL1 (PDB ID 6M5N) sharing 30% of
sequence identity with SrBDH1, was solved.[25] The monomers
of PsBDH and SrBDH1 ·NAD+/high salt superimpose with a
RMSD of 1.52 Å for 230 pairs of Cα atoms (Figure 4A). The
largest differences between both structures are located in the
last third of the amino acid sequence upstream of β-strand βF
(Figure 4A and B), affecting the putative borneol binding site. In
the structure of SrBDH1, the β-strand βF is connected by a
single α-helix αFG to αG, while in the structure of PsBDH we
find an insertion of two α-helices, αFG1 and αFG2. Moreover,
SrBDH1 contains an additional C-terminal α-helix αH that is
absent in PsBDH (Figure 4A, B, and C). Due to the differences in
fold and secondary structure content, amino acids that are
flanking the active site differ between both structures (Fig-
ure 4C, D, and E). Notably, the active site of SrBDH1 is further
shielded by the α-helix αH of a symmetry-related molecule
(Figure 4). The location of SrBDH1 αH is comparable to the α-
helix αFG2, which is more distant from the active site (Figure 4A
and B), but from the identical monomer. Our observations are
in accordance with previous publications stating that the C-
terminal portion generally functions in substrate binding, there-
fore, the obvious structural variation in this region results in the
diversity of substrate specificities.[26] A more detailed inspection
of the active site revealed, that except for I154 of SrBDH1, none
of the amino acids present the active site are conserved to
PsBDH.
Probing enantiospecificity by site-directed mutagenesis
Intrigued by these findings we proceeded to elucidate the
origin of specificity in BDH-type enzymes. Since soaking or co-
crystallization experiments with substrates failed in yielding a
crystal structure with a bound substrate, we performed docking
studies using both enantiomers of endo-1 a, exo-1 a and 1 b to
identify the most probable conformation in the active site. The
bicyclic monoterpenols endo-1 a and exo-1 a are compact
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tries or polar groups that could facilitate stereodiscrimination
by the enzyme. This was reflected in a large number of different
poses (8–12) obtained in docking experiments (using a min
RMSD of 2 Å for clustering). To identify productive binding
modes, we lowered the clustering threshold to get more poses.
We considered a pose to be productive when the hydrogen in
α position from the hydroxyl group was located towards NAD+
and the hydrogen of the hydroxyl group was in range (d <4 Å)
with the catalytic residues S146 and Y159 (Figure 5).[24] The low
ratio of productive binding mode is in agreement with the very
Figure 4. (A) In cartoon representation, a superposition of one monomer of SrBDH1 and PsBDH. Identical view as in Figure S7. SrBDH1 is shown in blue and
PsBDH in violet. The C-terminal α-helix (αH) of a symmetry-related molecule, that shields the active site, is shown in green cartoon representation. The NAD+
bound to SrBDH1 is shown as brown sticks. (B) View of panel (A) rotated by 45°. (C) Structure-based sequence alignment of SrBDH1 and PsBDH PDB-ID:
6M5N. The secondary structure elements are shown above the alignment for SrBDH1 and below for PsBDH with α-helices depicted as cylinders and β-strands
as arrows. Inclined lines indicated sections of SrBDH1 and PsBDH, that are not included in modelled the crystal structures. The catalytic motif is indicated by
orange triangles. Amino acids lining the putative active site of SrBDH1 are indicated by blue triangles and as green triangle if derived for another SrBDH1
monomer within the tetramer. (D) Stick representation of residues lining the active site of SrBDH1 with bound NAD+. The active is site is defined mainly by
hydrophobic amino acid residues from two symmetry-related protein monomers colored in blue and green, respectively. (E) Stick representation of residues
lining the active site of chain C with the bound NAD+ and PsBDH in violet. The active is site is defined mainly by hydrophobic amino acid residues from two
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high KM of the enzyme. Docking of exo-1 a yielded one
productive pose for each enantiomer. In the case of endo-1 a,
the preferred (+)-enantiomer led to a productive binding
mode, whereas no productive pose was found for the
(  )-enantiomer. In this last case, we forced (  )-endo-1 a in a
hypothetical binding mode in the crystallographic structure of
the enzyme in order to study how we could enable its
conversion (Figure 5B). When (+)-endo-1 a was soaked into
crystals of SrBDH1 prior to structure determination, an addi-
tional patch of electron density (data not shown) was revealed.
The volume and location of this additional electron density is in
good agreement with the modeled position of (+)-endo-1 a. To
further verify that the missing binding mode for (  )-endo-1 a
might be possible, the same ligands were docked in the newly
structurally characterized unselective BDH from Pseudomonas
sp. TCU-HL1 (PsBDH, PDB-ID: 6M5N).[23] In this case, a productive
binding mode for (  )-endo-1 a could be found. The PsBDH
seems to have more space in the hydrophobic pocket of the
active site. However, the significantly different secondary
structure in the active-site pocket made it difficult to pinpoint
concrete differences that could explain why productive poses
for all ligands could be found in this dehydrogenase (Figure 4A
and B).
The docking results highlighted two main potential differ-
ences between the positioning of the isomers. First, borneol
and isoborneol seem to fit differently in the pocket. In
particular, the two methyl groups in C7 assume a different
position. Second, the methyl group in the chiral C1 in the
binding modes of preferred (Figure 5A and C) and non-
preferred enantiomers (Figure 5B and D) points in opposite
directions.
The crystallographic and docking studies served as a
starting point for the selection of active site residues that might
have a significant effect on stereospecificity. Furthermore, two
strategies were combined to create variants with decreased
specificity allowing us to identify residues that are responsible
for the excellent enantiodiscrimination in SrBDH1 enzyme. The
first strategy was to introduce residues found in the active site
of non-specific BDHs that differed from ones at the same
positions in SrBDH1 (Table S4). The second strategy was to use
the coupled moves protocol implemented in the Rosetta
framework by Ollikainen et al.[27] for the four isomers of 1 a. The
Rosetta protocol was designed to change substrate specificity
by redesigning the active site of a certain enzyme. Specifically,
for each isomer we obtained a set of positions in which certain
residues could possibly have a positive impact on the binding
energy of the enzyme for the isomer. We hypothesized that
positions, where the enriched residues were different for each
enantiomer, are important for the specificity of SrBDH1. The
coupled moves highlighted positions such as V97F/Y, G99T/P,
C148 A or I196 L (Figure S9). Table 4 shows the effect of amino
acid substitutions in the active site on the specificity towards
endo-1 a and exo-1 a. Mutagenesis points out the residues V97
and G191 as determinants of enantiospecificity for exo-1 a.
Valine 97 is located in direct vicinity to the cofactor and the
substrate and is likely to exert an influence on substrate
recognition. The coupled moves protocol suggested multiple
mutations at this position, making us think that it might be an
important site for enantiospecificity. However, the decision to
substitute V97 by proline was made after observing that several
non-specific BDHs have a proline in the analogous position.
Indeed, V97P has a reduced specificity (E=15), while conver-
sions were similar to those of the wildtype enzyme. In
Figure 5. Docking results of (+)-endo-1 a (A), (  )-endo-1 a (manually docked, B), (+)-exo-1 a (C), (  )-exo-1 a (D) in the active site of SrBDH1. Endo-1 a
enantiomers seem to be located in the active site in a different orientation compared to exo-1 a enantiomers, but the most striking difference is the methyl
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homology models of the non-specific AaADH2, the equivalent
proline is in a loop that strongly differs from that of SrBDH1
(Figure S10). As V97P might have consequences on the protein
backbone conformation of this loop, its effect on the
enantiospecificity is not easy to rationalize. Glycine 191 is
positioned at the opposite side of the active site (Figure 5) and
its methylene group has a distance of 4 Å to both the
nicotinamide moiety of the cofactor and the substrate.
Exchanging G191F was done due to the presence of this residue
in several non-specific BDHs (Figure S1, Table S4) and led to a
considerable reduction of activity towards exo-1 a. F191 could
undergo π-stacking with F207 and lead to rearrangement of
this part of the active-site pocket. However, there is no obvious
explanation why the V97P and G191F substitutions increase
(  )-exo-1 a proportional formation, but do not affect the
specificity for (  )-endo-1 a. Substitutions in M211 by valine and
leucine showed a slight increase in the specificity for exo-1 a,
while maintaining the high specificity for endo-1 a. M211 is
located in an α-helix that has not equivalent structure in PsBDH
(Figure 4), at the opposite side of the active site where the
hydroxyl group of the substrate is located (Figure 5).
The mechanisms underlying the enantiospecificity of many
enzymes are often characterized by well-defined steric and
electronic interactions. The different sizes of the two substitu-
ents of secondary alcohols guide the stereospecificity of
lipases.[28] Both (S)-specific and (R)-specific amine transaminases
employ binding pockets for the accommodation of large and
medium-sized prochiral ketones, which often results in out-
standing specificity.[29,30] The stereoselectivity of ketoreductases
in the asymmetric reduction of prochiral ketones follows the
same principle.[31] Many enzyme classes bind their substrates
with a multitude of polar interactions, which allows them to
discriminate between different polar groups on the substrate
molecule;[32] this principle allows carbohydrate-converting en-
zymes a tremendous specificity toward molecules with several
functional groups of similar reactivity.[32] In contrast, the stereo-
specificity of plant SDR for bicyclic monoterpenols endo-1 a and
exo-1 a is a curious case, as their carbon skeleton is rigid and
does not have any rotational degrees of freedom. The compact
bornane-type structure does not show any obvious steric
differences (such as a large and a small substituent) that would
facilitate discrimination between both enantiomers. Possibly,
endo-1 a and exo-1 a present minor steric differences in the
accessibility of hydrogen in the chiral C1; in exo-1 a this
hydrogen is on the same plane as the methyl groups in C7
whereas in exo-1 a it is on the less sterically-crowded plane. This
minor difference might explain the preference of most enzymes
for exo-1 a in the reverse reaction, here the hydride from NADH
should access the less sterically-crowded plane resulting in exo-
1 a. The positioning of the substrate can be deduced from the
required short distances from C1-H to the cofactor, and OH  H
to S146 and Y159. Other than these, there are no clearly defined
interactions between the substrate and the hydrophobic active
site of SrBDH1 that could explain its very high specificity
towards racemic endo-1 a and exo-1 a. SrBDH1 preferentially
converts (+)-endo-1 a and (+)-exo-1 a and shows scarce activity
towards the (  )-enantiomers. Mutagenesis of 6 of the 8
residues of the active-site pocket (the remaining two being
highly conserved) led to the identification of two variants that
additionally convert (  )-exo-1 a, but, not (  )-endo-1 a. This
corresponds to the observation that in docking experiments,
only (  )-endo-1 a did not form a productive binding mode. It is
Table 4. Conversion and enantiospecificity for the kinetic resolutions of endo-1 a and exo-1 a for the point mutants tested. The reaction mix contained 1 mM
substrate, 1 mM of NAD+ and was incubated at 20 °C for 30 min before extraction for GC analysis.
endo-1 a exo-1 a
Mutant E[a] [%]c[a] E[a] [%] c[a]
SrBDH1 >200 50% 132 53%
V97G[b] >200 7% >200 4%
V97C[c] >200 50% 47 45%
V97P[c],[b] >200 41% 15 38%
V97F[d] >200 10% 14 8%
V97Y[d] >200 4% >200 1%
G99 N[c] >200 37% >200 27%
G99H[c][e] n.c.[f] n.c. n.c. n.c.
G99D[c] >200 43% >200 38%
G99T[d] >200 50% 76 51%
C148A[d] >200 50% >200 51%
F190Y[d] >200 47% >200 43%
G191M[c] >200 48% >200 49%
G191S[c] >200 17% >200 14%
G191F[c] >200 11% 4 15%
I196L[c] >200 20% >200 14%
F207W[d] n.c. n.c. n.c. n.c.
M211V[b],[c] >200 50% >200 50%
M211L[c] >200 50% >200 50%
[a] Calculated from eep and ees that were determined by chiral gas chromatography, [b] Selected according to docking results, [c] Selected according to
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not clear whether the enantiospecificity towards endo-1 a, the
presumed natural substrate of these SDRs, has any evolutionary
advantages for the plant. However, a possible benefit might be
the possibility of specific oxidation of (+)-endo-1 a to (+)-2 a in
the presence of (  )-endo-1 a. Indeed, the essential oil of R.
officinalis contains both (  )-endo-1 a and (  )-exo-1 a. In view of
the very high enantiospecificity of R. officinalis towards borneol
and the fact that its specificity was not affected by single-site
mutagenesis, it is indeed striking that a few of the investigated
borneol-dehydrogenases show specificity (Figure 1).
Conclusion
A selected set of short-chain borneol-type dehydrogenases
were characterized in this study in terms of substrate accept-
ance and specificity. All enzymes converting the substrates
showed some extent of preference for (+)-endo-1 a and (+)-exo-
1 a over their specular images, with the novel SrBDH2
presenting outstanding specificity for (+)-endo-1 a and SrBDH1
for both of them. The kinetic resolution of endo-1 a utilizing
SrBDH1 produces optically pure (+)-1 b and allows the isolation
of the unreacted (  )-endo-1 a. In the case of exo-1 a, SrBDH1
yields (  )-1 b and (  )-exo-1 a in optically pure form. The high
activity, stability and specificity of SrBDH1, make this enzyme a
promising biocatalyst for the preparation of optically pure
endo-1 a, exo-1 a, (+)-1 b and (  )-1 b. Therefore, enzymatic
catalysis utilizing SrBDH1 could substitute the currently used
extraction from plants, which is unfavorable from both the
environmental and economical point of view.
The distribution of enantiospecificity enzymes observed in
the phylogenetic tree indicates that either the ability to oxidize
borneol evolved independently several times during evolution
or that a borneol oxidizing ancestor existed and some
descendants lost the affinity for this substrate. Further charac-
terization of different alcohol dehydrogenases belonging to
SDR110 C group would be necessary in order to have a more
complete and correct interpretation of the evolution of this
family.
The structure of SrBDH1 showed a predominantly hydro-
phobic catalytic pocket. A comparison with the non-specific
PsBDH revealed major differences in the structure and amino
acids shaping the active site pocket. Docking of the enantiom-
ers of endo-1 a, exo-1 a and 1 b was performed with SrBDH1
structure. These results displayed productive binding modes for
(+)-endo-1 a, (+)-exo-1 a and (  )-exo-1 a, but not for (  )-endo-
1 a. This is in agreement with the directed mutagenesis study,
where the specificity for (+)-endo-1 a remained high for all
mutations, whereas we could significantly reduce it for exo-1 a
with mutations at positions V97, G99 and G191. Despite the
high structural similarity between endo-1 a and exo-1 a, SrBDH1
can discriminate between the diastereoisomers. In fact,
(+)-endo-1 a, the supposed natural substrate, shares the same
backbone with (  )-exo-1 a, still the found binding mode of
(+)-endo-1 a would be unproductive for (  )-exo-1 a. Productive
binding modes for both substrates seem to depend on different
interactions making it difficult to alter the specificity with point
mutations only. This study describes a curious case of
enantiospecificity and shows that this feature, in the case of
unfunctionalized molecules, can be achieved in nature relying
only on multiple weak interactions. Based on our results, the
specificity of borneol-type SDRs appears to be more robust to
point mutations compared to lipases, transaminases, ketoreduc-
tases or carbohydrate-converting enzymes. A combinatorial
mutagenesis approach such as CASTing could highlight
hotspots with epistatic effects, which are extremely difficult to
highlight with point mutations only. Nevertheless, the identi-
fication of a highly active, stable and specific SrBDH1 in a still




All chemicals were bought from Sigma Aldrich (Germany), except
for (+)-endo-2 a (1S,2R,4R) (AaBlocks, USA) and used without further
purification. E. coli strain BL21 (DE3) was used for expression.
Protein and DNA concentration were measured using a Nanodrop
2000 UV-Vis spectrophotometer (Thermo Scientific, USA) at 260 and
280 nm respectively. Absorbance at 340 and 550–800 nm was
measured using an Eon plate reader (BioTek, USA). The enzymes
were purified using ÄKTA pure system (GE Healthcare Life Sciences,
Austria).
The genes were ordered at GeneScript (USA), codon-optimized for
E. coli and cloned into the vector pET15b in frame with an N-
terminal poly-histidine tag.
Phylogenetic tree and alignment
Evolutionary analyses were conducted in MEGA X.[33] The evolu-
tionary history was inferred by using the Maximum Likelihood
method and Le_Gascuel_2008 model.[34] The tree with the highest
log likelihood is shown in Figure 1. Initial trees for the heuristic
search were obtained automatically by applying Neighbor-Join and
BioNJ algorithms to a matrix of pairwise distances estimated using
a JTT model, and then selecting the topology with superior log
likelihood value. A discrete Gamma distribution was used to model
evolutionary rate differences among sites (5 categories (+G,
parameter=1.5189)). The rate variation model allowed for some
sites to be evolutionarily invariable ([+ I], 0.26% sites). Evolview v2
was used for visualization.[35]
Protein expression and purification
Protein expression and purification of AaADH2, PsBDH, SoBDH1
and SoBDH2 were done as described before.[1] Briefly, for SrBDH1,
SrBDH2 and SoBDH3, E. coli BL21 (DE3) chemo-competent cells
were transformed with the constructs. Overnight cultures of
12.5 mL were used to inoculate flasks of 500 mL of LB media
supplemented with of ampicillin (100 mg L  1 final concentration).
The flasks were shaken at 130 rpm at 37 °C for 3.5 h (until OD600
between 0.6-0.8 was reached). The cultures were then induced with
of IPTG (1 mM final concentration) and shaken overnight at
130 rpm at 28 °C.
Cells were harvested by centrifugation (Beckman Coulter, USA, JA10
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in 20 mL of lysis buffer (20 mM Tris-HCl, 500 mM NaCl, 1 mM DTT,
10% glycerol, 20 mM imidazole, pH 8). The resuspended cells were
sonicated for 6 min, output control 7, duty cycle 70% and then
centrifuged at 13,000 rpm for 45 min at 4 °C. The supernatants were
recovered, filtered with 0.45 μm filters and loaded into pre-
equilibrated His-Trap FF crude 5 mL columns (GE-Healthcare,
Austria) for affinity chromatography purification. The loaded
columns were washed with 50 mL of binding buffer (20 mM Tris-
HCl, 500 mM NaCl, 10% glycerol, 30 mM imidazole, pH 8). The
purified enzymes were eluted using 30 mL of elution buffer (Tris-
HCl 20 mM, 500 mM NaCl, 10% glycerol, 300 mM imidazole, pH 8)
and dialyzed overnight with storage buffer (Tris-HCl 20 mM,
500 mM NaCl, pH 8). If needed, the enzymes were concentrated
using Amicon® Ultra 10 K centrifugal filter (Merck KGaA, Germany).
The enzymes were aliquoted and stored with a final concentration
of 10% glycerol at   20 °C. Following the purification, the fractions
were analyzed by SDS-PAGE electrophoresis on 12% polyacryla-
mide gels (ExpressPlus™ PAGE Gel, Genscript, USA) followed by
staying with Coomassie Brilliant Blue. Protein concentration was
determined by measuring absorbance at 280 nm. The extinction
coefficients for the enzymes were obtained from ExPASy ProtParam
Tool (https://web.expasy.org/protparam/). The ɛ280 for the mono-
mers of the enzymes correspond to 9,190 M  1 cm  1 for SrBDH1,
10,680 M  1 cm  1 for SrBDH2, and 13,200 M  1 cm  1 for SoBDH3.
Size exclusion chromatography
Size exclusion chromatography was carried using a HiLoad™ 16/60
200 Superdex™ column (GE Healthcare). The column was equili-
brated overnight with buffer Tris-HCl 100 mM, 500 mM of NaCl,
pH 8. 500 μL samples were injected and then eluted at a flow of
1 mL min  1 in 1.5 column volumes. A calibration curve was
elaborated using Gel Filtration Cal Kit High Molecular Weight (GE
Healthcare). The molecular mass standards used were Ovalbumin
(44 kDa), Conalbumin (75 kDa) Aldolase (158 kDa) and Ferritin
(440 kDa).
Determination of conversion, enantiomeric excess and E
value for the oxidative and reductive reactions
For the oxidations, a reaction volume of 1 mL containing the
alcohol dehydrogenase (15 μM of the monomer of AaADH2, PsBDH,
SoBDH1, SoBDH2, SoBDH3, SrBDH1, SrBDH2), 1 mM of NAD+, 1 mM
of substrate (endo-1 a, exo-1 a, exo-2 a or endo-3 a) in buffer Tris-HCl
100 mM, 500 mM of NaCl, pH 8 at 20 °C, 600 rpm was used. Samples
of 200 μL were taken at different time points for gas chromatog-
raphy analysis. All the reactions were done in duplicate.
A colorimetric screening based in phosphate detection[36] was used
to identify activity for the reductive reaction of the enzymes. The
reactions were prepared in a 96 deep well plate by triplicate. The
reaction mix of 1 mL consisted in 15 μM (monomer) of the alcohol
dehydrogenase determined by the absorption at 280 nm (AaADH2,
PsBDH, SoBDH1, SoBDH2, SoBDH3, SrBDH1 or SrBDH2), 20 μM of
NADH, 10 mM of sodium phosphite, 12 μM of phosphite dehydro-
genase and 5 mM of substrate (1 b, 2 b or 3 b) in citrate buffer
(50 mM, 500 mM NaCl, pH 5.5). The reactions were incubated at
20 °C, 200 rpm for 48 h. Samples of 200 μL were taken at 0, 24 and
48 h and frozen with liquid nitrogen. For phosphate measurement,
a mix of 200 μL of molybdate reagent ((CH3CO2)2Zn 100 mM,
ammonium molybdate ((NH4)6Mo7O4.4H2O) 10 mM, pH 5 adjusted
with HCl), 50 μL of ascorbic acid solution (L-(+)- ascorbic acid 10%,
pH 5 adjusted with NaOH) and 20 μL of sample was put together in
a 96 well plate. After 30 min at 37 °C, absorbance in the range
between 550–800 nm was measured. A calibration curve with
known phosphate concentrations from 0 to 10 mM (triplicate) was
used for interpretation of the results. The reactions that after 48 h
showed some level of conversion were extracted and analyzed by
GC-FID.
Determination of kinetic parameters and specific activities
Kinetic parameters were determined measuring NADH formation at
340 nm. Reaction mixes were prepared in 96 well plates for UV
measurement by triplicate. For (+)-endo-1 a kinetic study: 0.5 μM of
SrBDH1 (tetramer), 1 mM NAD+, (+)-endo-1 a in a range between
0.5 and 6 mM, 5% DMSO, buffer Tris-HCl 100 mM pH 9. For NAD+
kinetic study: 0.5 μM of SrBDH1, NAD+ in a range between 0.05 and
2 mM, 5 mM of (+)-endo-1 a, 5% DMSO, buffer Tris-HCl 100 mM
pH 9. All the reactions were started adding NAD+ to the reaction
mix. Absorbance at 340 nm was measured every 15 s for 30 min.
The linear range of the curves was used to calculate the initial rates.
Origin 2019b (OriginLab Corporation, USA) was used for the
nonlinear fitting using Michaelis-Menten model to obtain the
kinetic parameters.
Specific activities were obtained in a similar way under the
following conditions: 20 μM of the alcohol dehydrogenase (mono-
mer) (AaADH2, PsBDH, SoBDH2, SoBDH3, SrBDH1 or SrBDH2), 2 mM
NAD+, 2 mM of substrate, 1% DMSO in Tris-HCl 100 mM pH 9.
Optimum pH determination for SrBDH1
SrBDH1 was incubated for 30 min on the following buffers: citrate
buffer 100 mM for pH 4.5, 5 and 5.5; potassium phosphate buffer
100 mM for pH 6, 6.5 and 7; Tris-HCl buffer 100 mM for pH 7.5, 8,
8.5 and 9; carbonate-bicarbonate buffer 100 mM for pH 9.5, 10 and
10.5. After that time, 5 μL of the incubated enzyme were added to
a mix consisting in 4 mM of (+)-endo-1 a, 5% DMSO, 5 mM NAD+,
0.15 μM of SrBDH1 in buffer Tris-HCl 100 mM pH 9 in a final volume
of 200 μL. Absorbance at 340 nm was measured every 15 seconds
for 45 min. The linear range of the curves was used to calculate the
initial rates of reaction. All the reactions were done by triplicate.
Gas Chromatography-flame ionization detector (GC-FID)
analysis
GC-FID analysis was carried using a Shimadzu QP2010 SE GC-FID
system. All extractions were performed using 400 μL of DCM and
200 μL of sample at 0, 24 and 48 h. After mixing and discarding the
inorganic phase, the samples were dried using Na2SO4, centrifuged
and transferred to 1.5 mL vials with 200 μL inserts. For 1 a, 1 b, exo-
2 a and 2 b, an Hydrodex β-6TDM chiral column (Macharey-Nagel)
(25 m, 0.25 mm I.D., 0.25 μM film thickness) was used with the
following program: 60 °C for 8 min, a linear increase of 2 °C/min to
150 °C, a linear increase of 40 °C/min to 200 °C, 200 °C for 2 min. For
endo-3 a and 3 b, an Hydrodex-β-6TBDAc chiral column (Macharey-
Nagel) (50 m, 0.25 mm I.D., 0.25 μM film thickness) was used with
the following program: 50 °C for 15 min, a linear increase of 1 °C/
min to 110 °C, a linear increase of 20 °C/min to 220 °C, 220 °C for
1 min.
Protein expression and protein purification for crystallization
experiments
E. coli BL21-RIL was transformed with pET15a vector containing
SrBDH1 fused to an N-terminal hexa-histidine-tag. Protein induction
was carried in auto-induction media at 37 °C for 7 h and
subsequently cooled down to 16 °C.[37] Cells were grown over night
and harvested by centrifugation (10 min, 7,000 rpm at 4 °C). The
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500 mM NaCl). Cells were lysed by homogenization at 4 °C for 7 min
after addition of 0.5 mg l  1 DNase and the lysate was cleared by
centrifugation (30 min, 21’500 rpm at 4 °C). Ni2+-NTA beads (cv
1 ml, GE Healthcare) were equilibrated with buffer A. SrBDH1 was
loaded on the column and washed with 15 cv of buffer A. SrBDH1
was eluted using a linear gradient with increasing imidazole
concentration up to 300 mM. Size exclusion chromatography (SEC)
was performed with a HighLoad Superdex S200 16/60 column (GE
Healthcare), equilibrated with buffer B (20 mM Tris/HCl, pH 8.0,
125 mM NaCl). Pooled protein fractions were concentrated with
Amicon-Ultra-15 (Merck KGaA) to 27.3 mg ml  1 as measured by the
absorbance at 280 nm.
Crystallization
Crystals were obtained by the sitting-drop vapor-diffusion method
at 18 °C with a reservoir solution composed of 0.1 M Bis-Tris/HCl
pH 5.5 to pH 7.2, and NaCl ranging from 2.7 M to 3.2 M. Crystals
were cryo-protected with 25% (v/v) glycerol supplemented to the
reservoir resolution and subsequently flash-cooled in liquid nitro-
gen. A second crystallization condition was obtained with a
reservoir solution composed of 0.1 M HEPES/NaOH pH 7.0 to
pH 7.8, 5/4 pentaerythritol propoxylate (PO/OH) 25% (v/v), 30%,
35%, 0.1 M and 0.2 M KCl. Crystals were cryo-protected with 15%
(v/v) glycerol supplemented to the reservoir resolution and
subsequently flash-cooled in liquid nitrogen.
Soaking and co-crystallization experiments
Crystals were soaked for 70 min in (+)-borneol (80 mM from
400 mM stock in 100% DMSO) containing cryo-protectant and
subsequently flash-cooled in liquid nitrogen. For co-crystallization
20 mM (+)-borneol (from 100 mM stock in 100% ethanol) were
added to the protein solution and incubated for 1 h on ice prior
crystallization. Crystals were cryo-protected as above and subse-
quently flash-cooled in liquid nitrogen.
Diffraction data collection, structure determination and
refinement
Synchrotron diffraction data were collected at the beamline 14.1
and 14.2 of the MX Joint Berlin laboratory at BESSY (Berlin,
Germany). X-ray data collection was performed at 100 K. Diffraction
data were processed with XDS[38] (Table S3). The structure for the
SrBDH1 apo was solved via molecular replacement in PHASER[39] by
using the structure of the ternary-secoisolariciresinol dehydrogen-
ase from Podophyllum petatum (PDB ID 2bgm[40]) as search model.
Crystals of SrBDH1 apo belong to the space group P41212, with two
molecules in the asymmetric unit. Model building and water
picking were performed with COOT.[41] The structure was initially
refined by applying a simulated annealing protocol and in later
refinement cycles by maximum-likelihood restrained refinement
using PHENIX.refine.[42,43] The crystals of SrBDH1 NAD+ crystallized
in space group P65 and the structure was solved by molecular
replacement with the SrBDH1 structure, computed from the crystals
of the high salt condition, as search model. Model quality was
evaluated with MolProbity[44] and the JCSG validation server.[45]
Figures were prepared using PyMOL (Schrödinger, Inc). Secondary
structure elements were assigned with DSSP,[46] and ALSCRIPT[47]
was used for secondary structure-based sequence alignments.
Structure factor amplitudes and coordinates have been deposited
in the ProteinDataBank.
Multi-angle light scattering (MALS)
MALS experiment was performed at 18 °C. SrBDH1 was loaded onto
a Superdex 200 increase 10/300 column (GE Healthcare) that was
coupled to a miniDAWN TREOS three-angle light scattering
detector (Wyatt Technology) in combination with a RefractoMax520
refractive index detector. For calculation of the molecular mass,
protein concentrations were determined from the differential
refractive index with a specific refractive index increment (dn/dc) of
0.185 ml g  1. Data were analyzed with the ASTRA 6.1.4.25 software
(Wyatt Technology).
Docking studies
(+)-endo-1 a, (  )-endo-1 a, (+)-exo-1 a, (  )-exo-1 a, (+)-1 b and
(  )-1 b were energy minimized using a MM2-force field for
molecular docking into the active site of a monomeric representa-
tion of SrBDH1 and PsBDH (PDB-ID: 6M5N). The docking was
performed using the AutoDockVina program environment of
YASARA Structure.[48,49] All 6 substrate structures were docked into a
simulation cell (X size=16 Å, Y size=16 Å, Z size=16 Å; angles: α=
90°, β=90°, γ=90°) extended 1 Å around the residues I96, I154,
G195 and I210 in SrBDH1 and the corresponding residues V95, I152,
M193 and A208 in PsBDH. For each substrate, 999 docking runs
were performed with atoms and bonds of the corresponding
substrates set as flexible. Docking of each substrate resulted in one
or more clusters using a rmsd cutoff for clustering of 2.0 Å.
Coupled moves
The SrBDH1 structure was pre-processed by running the Relax
protocol with (+)-endo-1 a in the active site to minimize artefacts in
the following protocol. The ligand rotamer library was generated
by the free online tool Frog2[50] with default options. The coupled
moves protocol was run according to published setting[27] (com-
mand line) as reported in the Supplementary Information.
The resulting output sequences were filtered for redundancy and
analyzed using the script analyze_coupled_moves.py made avail-
able by the Kortemme lab in github.com[51] which allows high-
lighting of the top 10 mutations enriched in the ligand of interest
compared to a known accepted ligand and furthermore it allows
the visualization of results via WebLogo.[52] In all cases the Rosetta
version 3.11 was used.
Point Mutations
The QuikChange method (Agilent Technologies) was used for site-
directed mutagenesis. For the complete list of the primers used,
please refer to the Supplementary Table S5). After PCR for the
insertion of the mutants in pET15b_SrBDH1 plasmid, 10 U DpnI
were added to the mix and incubated at 37 °C for 1 h. Chemo-
competent E. coli Top 10 cells were transformed using 3 μL of the
mix. The mutants were confirmed by sequencing and retrans-
formed in E. coli BL21 (DE3).
Cell-free extract of SrBDH1 mutants was obtained as described
before for the wild type. For biotransformations, 1 mM of endo-1 a
or exo-1 a, 1 mM of NAD+ and 975 μL of cell-free extract were used,
for a total reaction volume of 1 mL. Samples of the reaction after
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SrBDH1 Borneol-type dehydrogenase 1 from Salvia Rosmarinus
SrBDH2 Borneol-type dehydrogenase 2 from Salvia Rosmarinus
SoBDH3 Borneol-type dehydrogenase 3 from Salvia officinalis
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CCL2 CC chemokine ligand 2
CCR5 CC chemokine receptor 5
TLC thin-layer chromatography
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